Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aryx’s Constipation Drug Boosts Bowel Function

This article was originally published in The Pink Sheet Daily

Executive Summary

Despite good results, GI agent takes back seat to firm’s promising late-stage heart drugs.

You may also be interested in...



Cash Constraints Force Industry To Retool Its Opinion Of PIPEs

Private investments in public equity help firms reach inflection points.

Cash Constraints Force Industry To Retool Its Opinion Of PIPEs

Private investments in public equity help firms reach inflection points.

Vernakalant, Cardiome Limelight Could Make ARYx Glow

Amiodarone-derived, Phase II atrial fibrillation drug might prove even better, ARYx tells “The Pink Sheet” DAILY.

Related Content

Topics

UsernamePublicRestriction

Register

PS068263

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel